학술논문

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Document Type
Artikel
Source
EBioMedicine. 66:103327
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
2352-3964